Related references
Note: Only part of the references are listed.Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients
C. Fiuza-Luces et al.
BONE MARROW TRANSPLANTATION (2016)
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Irwin Walker et al.
LANCET ONCOLOGY (2016)
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Nicolaus Kroeger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Rabbit Anti-T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation
Jan Storek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Shernan G. Holtan et al.
BLOOD (2015)
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2015)
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Christopher G. Kanakry et al.
BLOOD (2014)
Acute graft-versus-host disease: a bench-to-bedside update
Shernan G. Holtan et al.
BLOOD (2014)
In vivo T-Cell Depletion with Antithymocyte Globulins Improves Overall Survival after Myeloablative Allogeneic Stem Cell Transplantation in Patients with Hematologic Disorders
Zhixin Sheng et al.
ACTA HAEMATOLOGICA (2013)
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis
Sebastian Theurich et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
Marcelo C. Pasquini et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review
A. Kumar et al.
LEUKEMIA (2012)
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Robert J. Soiffer et al.
BLOOD (2011)
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
Gerard Socie et al.
BLOOD (2011)
Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
John R. Wingard et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution
Ronjon Chakraverty et al.
BLOOD (2010)
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants
A. Bacigalupo et al.
BONE MARROW TRANSPLANTATION (2010)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Juergen Finke et al.
LANCET ONCOLOGY (2009)
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies:: A 10-year retrospective analysis from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Mauricette Michallet et al.
EXPERIMENTAL HEMATOLOGY (2008)
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
M. Mohty
LEUKEMIA (2007)
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens
Richard E. Champlin et al.
BLOOD (2007)
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: Long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation
A Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
A Bacigalupo
BONE MARROW TRANSPLANTATION (2005)
Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation:: a 1-yr follow-up of safety and efficacy
M Büchler et al.
CLINICAL TRANSPLANTATION (2003)
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
A Bacigalupo et al.
BLOOD (2001)
Share Paper
